We are committed to transforming the lives of people affected by cancer or rare disease, globally. We continuously strive to uncover opportunities which address gaps across adult and paediatric care. Helping the people with few or no options available is at the heart of everything we do. EUSA Pharma is part of Recordati Rare Diseases (recordatirarediseases.com), the business unit dedicated to rare disease in the Recordati group. Recordati has a total staff of more than 4,300, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. More information can be found in the press release: https://www.recordati.com/resources/Pubblicazione/___58a6bc05f57c4861aae203c930cd1682_/eusa-closing-pr.pdf We see a need. We work together. We don’t give up.
Looking for a particular EUSA Pharma employee's phone or email?
The EUSA Pharma annual revenue was $67.5 million in 2026.
Thomas Equels is the President of EUSA Pharma.
79 people are employed at EUSA Pharma.
The NAICS codes for EUSA Pharma are [325, 4242, 424, 42, 42421, 32].
The SIC codes for EUSA Pharma are [283, 28].